While our work provided insight into the influence of CD73 and CSCs on tumor-infiltrating lymphocytes, future studies might involve investigating metastatic tumors post-treatment as a measure of disease recurrence (61, 65), or employing humanized mouse models to evaluate translatability of our findings regarding tumor-infiltrating human lymphocytes (66). The gene discussed is NT5E; the disease is neoplasm.